سعر اكسيدوليب 1جم 30 كبسولة 2024

Icosapent ethyl 1 g oral soft gelatin capsules (Arab Caps for Xeedia pharma), pack of 30.

• Adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization and unstable angina requiring hospitalization in adults with elevated triglycerides (>=150 mg/dL) and established cardiovascular disease or diabetes mellitus and 2 or more additional risk factors for cardiovascular disease.Population: AdultsDailyMed (U.S. NLM)
• Adjunct to diet to reduce triglyceride levels in adults with severe (>=500 mg/dL) hypertriglyceridemia.Population: AdultsDailyMed (U.S. NLM)
• EU: to reduce the risk of cardiovascular events in adult statin-treated patients at high cardiovascular risk with elevated triglycerides (>=150 mg/dL) and established cardiovascular disease, or diabetes and at least one other cardiovascular risk factor.Population: AdultsEuropean Medicines Agency

• Common adverse reactions in the cardiovascular outcomes trial (incidence >=3% and more frequent than placebo): musculoskeletal pain, peripheral edema, constipation, gout and atrial fibrillation; in the hypertriglyceridemia trials: arthralgia and oropharyngeal pain.International label, same formulation · DailyMed (U.S. NLM)

• Known hypersensitivity (e.g., anaphylactic reaction) to icosapent ethyl or any of its components.International label, same formulation · DailyMed (U.S. NLM)

• Increased risk of atrial fibrillation or atrial flutter requiring hospitalization, greater in patients with a history of AF/flutter.International label, same formulation · DailyMed (U.S. NLM)
• Contains EPA ethyl esters obtained from fish oil; it is not known whether patients with fish and/or shellfish allergy are at increased risk of allergic reaction; inform such patients and advise them to stop and seek medical attention if a reaction occurs.International label, same formulation · DailyMed (U.S. NLM)
• Increased risk of bleeding, particularly with concomitant antithrombotic medicines (aspirin, clopidogrel, warfarin).International label, same formulation · DailyMed (U.S. NLM)

• Anticoagulants and antiplatelet agentsIncreased risk of bleeding; monitor patients receiving icosapent ethyl with anticoagulants and/or antiplatelet agents.DailyMed (U.S. NLM)

• Available data from published case reports and pharmacovigilance are insufficient to identify a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.International label, same formulation · DailyMed (U.S. NLM)
• Omega-3 fatty acids such as EPA are present in human milk; consider developmental and health benefits of breastfeeding alongside the mother's clinical need.International label, same formulation · DailyMed (U.S. NLM)

English text not available for this section.